Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.240
-0.010 (-0.80%)
At close: Mar 27, 2026, 4:00 PM EDT
1.260
+0.020 (1.61%)
After-hours: Mar 27, 2026, 6:33 PM EDT
Tiziana Life Sciences Market Cap
Tiziana Life Sciences has a market cap or net worth of $158.25 million as of March 27, 2026. Its market cap has decreased by -1.98% in one year.
Market Cap
158.25M
Enterprise Value
151.11M
1-Year Change
-1.98%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since October 21, 2021, Tiziana Life Sciences's market cap has increased from $145.96M to $158.25M, an increase of 8.42%. That is a compound annual growth rate of 1.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 158.25M | -10.62% |
| Dec 31, 2025 | 177.05M | 133.12% |
| Dec 31, 2024 | 75.95M | 34.82% |
| Dec 29, 2023 | 56.33M | -7.14% |
| Dec 30, 2022 | 60.66M | -35.06% |
| Dec 31, 2021 | 93.41M | -36.00% |
| Oct 21, 2021 | 145.96M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Actinium Pharmaceuticals | 32.76M |
| Serina Therapeutics | 32.14M |
| INmune Bio | 31.90M |
| PDS Biotechnology | 31.35M |
| Tvardi Therapeutics | 31.24M |
| Jasper Therapeutics | 31.06M |
| Exicure | 29.38M |
| CEL-SCI | 29.35M |